FORA Capital’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-65,810
Closed -$3.06M – 614
2023
Q2
$3.06M Buy
+65,810
New +$2.27M 0.43% 67

FORA Capital's DICE Position: Q3 2023 in Review

FORA Capital sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 65,810 shares — an estimated $3.06M sold.

FORA Capital first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $3.06M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • FORA Capital reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • FORA Capital sold 65,810 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $3.06M.
  • FORA Capital first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • FORA Capital's DICE Therapeutics, Inc. Common Stock position peaked at $3.06M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on FORA Capital's 13F filing for Q3 2023, filed 13 Nov 2023.